Are you Dr. Mielcarek?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 19 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Ambulatory Clinic
825 Eastlake Avenue East
Seattle, WA 98109Phone+1 206-288-1000- Is this information wrong?
Summary
- Dr. Marco Mielcarek, MD is an oncologist in Seattle, Washington. He is currently licensed to practice medicine in Washington, Montana, and Hawaii. He is affiliated with Fred Hutchinson Cancer Center and UW Medicine/University of Washington Medical Center.
Education & Training
University of WashingtonFellowship, Hematology and Medical Oncology, 2000 - 2003- University of WashingtonResidency, Internal Medicine, 1998 - 2001
Freie University Berlin Faculty of MedicineClass of 1986
Certifications & Licensure
MT State Medical License 2022 - 2026
WA State Medical License 2000 - 2025
HI State Medical License 2018 - 2024- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Reduced-Intensity Conditioning Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Multiple Myeloma Start of enrollment: 2002 Oct 01
- Methotrexate and Glucocorticoids in Treating Patients With Newly Diagnosed Acute Graft-Versus-Host Disease After Donor Stem Cell Transplant Start of enrollment: 2006 May 01
- Autologous or Syngeneic Stem Cell Transplant Followed by Donor Stem Cell Transplant and Bortezomib in Treating Patients With Newly Diagnosed High-Risk, Relapsed, or Refractory Multiple Myeloma Start of enrollment: 2008 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- Outcomes in Hematopoietic Cell Transplant and Chimeric Antigen Receptor T Cell Therapy Recipients with Pre-Cellular Therapy SARS-CoV-2 Infection.Yoke, L., Roychoudhury, P., Flaherty, P., Oshima, M., Weixler, A., Gauthier, J., Greninger, A., Liu, C., Hill, J., Nimgaonkar, I., Mielcarek, M., Boeckh, M.> ;Clinical Infectious Diseases. 2024 Mar 1
- Differential Association between Blood Glucose Levels and Nonrelapse Mortality after Allogeneic Hematopoietic Cell Transplantation Based on Presence or Absence of Pree...Nahid Rashid, Ted Gooley, Michael Boeckh, Masumi Ueda Oshima, Jing H Chao, Irl B Hirsch, Marco Mielcarek> ;Transplantation and Cellular Therapy. 2024 Apr 1
- 1 citationsCryopreservation of Growth Factor-Mobilized Peripheral Blood Stem Cells Does Not Compromise Major Outcomes after Allogeneic Hematopoietic Cell Transplantation: A Singl...Laura Connelly-Smith, Ted Gooley, Laura Roberts, Marco Mielcarek, Michael Linenberger, Effie Petersdorf, Brenda M Sandmaier, Filippo Milano> ;Transplantation and Cellular Therapy. 2023 Nov 1
- Join now to see all
Press Mentions
- Patients Navigate Cancer During COVID-19 PandemicOctober 13th, 2020
How to Exceed 5-Year Post-Transplant Survival in the U.S.May 5th, 2018
Fred Hutch Doctor Takes on Life-Threatening Stem Cell Transplant ComplicationFebruary 13th, 2017- Join now to see all
Other Languages
- German
Hospital Affiliations
UW Medicine/University of Washington Medical CenterSeattle, Washington
Fred Hutchinson Cancer CenterSeattle, Washington
